We know that there is substantial variability between clinical commissioning groups (CCGs) and acute trusts in diabetes admission rates. There is strong evidence for models that reduce variability and overall admission rates, but these are often not commissioned, or are not available. This makes diabetes a priority for commissioning attention, with the potential for real and rapid improvement in admission rates.
JBDS-IP is supported by Diabetes UK, the Association of British Clinical Diabetologists (ABCD) and the Diabetes Inpatient Specialist Nurse UK Group. The aim of JBDS-IP is to improve inpatient diabetes care throughout the UK. This is mainly through the development and use of high quality evidence based guidelines, and through better inpatient care pathways.
Download Admissions Avoidance and Diabetes: Guidance for Clinical Commissioning Groups and Clinical Teams (PDF, 6.6MB)